Rare diseases
Investigational molecules
Locations
Grenzacherstrasse 124, 4058
F. Hoffmann-La Roche AG funds a broad oncology portfolio spanning breast cancer, non-small cell lung cancer, small cell lung cancer, hepatocellular carcinoma, colorectal cancer, and urothelial carcinoma, with additional activity in lymphoma, multiple myeloma, and other solid tumours.
Its oncology research also includes biomarker-defined disease groups such as HER2-positive, hormone receptor-positive, PIK3CA-mutated, KRAS G12C-mutated, and ALK-rearranged cancers.
F. Hoffmann-La Roche AG runs clinical trials in conditions such as Non-small cell lung cancer, Multiple sclerosis, Breast cancer, Breast cancer metastatic, among others.
Clinical trials run by this sponsor – those enrolling participants first.
Austria
Germany
Czechia
FranceAustriaAustria
BelgiumCzechiaBelgiumAustriaBelgiumFranceIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
